NCT01403896
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Capital Health District Authority Halifax, Nova Scotia, Canada
Clinical trial condition
Explore clinical trials studying Malignant Lymphoma, Stem Cell Type. Study availability and eligibility vary by location and protocol.
NCT01403896
NCT01171092